Ernst Amy A, Fish Susan
Department of Emergency Medicine, University of New Mexico, Albuquerque, NM 87131-0001, USA.
Acad Emerg Med. 2005 Nov;12(11):1050-5. doi: 10.1197/j.aem.2005.06.015.
Differences in interpretation of the Final Rule for exception from informed consent (EFIC) requirements for emergency research result in inconsistencies in implementation and difficulties for some institutional review boards (IRBs) to approve such research. During a consensus workshop organized by the editorial board of Academic Emergency Medicine, participants discussed how IRBs balance the risks to human subjects in EFIC research, the conduct of community consultation and its role in IRB decision making, and future directions to improve and research EFIC effects. Areas of consensus and diversity of opinion were identified. During the workshop, the National Institutes of Health model of consensus building was used to develop statements pertaining to specific questions of the effects, directions, implementation, and ultimate goals for emergency research using EFIC. The program was composed of an overview of the history and issues related to EFIC or Final Rule research and presentations of viewpoints of experts in this area of research. A final consensus was developed regarding the major topics, including IRB perspective, effective community consultation (often considered the main difficulty in implementing EFIC research), and goals for future directions and research on the topic. Roundtable discussions and breakout sessions involving interested parties were used as a format. In regard to how IRBs balance risks, by consensus it was agreed the regulations stipulate that EFIC studies must involve treatment that is unproven or unsatisfactory. The committee agreed that resuscitation rates are currently unsatisfactory, and thus current treatments are unsatisfactory. Many treatments currently used as standard care have never been proven to be effective. IRBs and the public need education that resuscitation research is needed. The same can be said for other conditions to which this rule applies. Because IRB expertise differs across the country, a group of peer reviewers to act as consultants should be available to help IRBs determine if current treatment for a condition is unproven or unsatisfactory. In regard to community consultation, the experiences of others are important and helpful as guidance. The amount and formats of community consultation should correspond to the amount of risk involved in the study proposed. In regard to future directions, communities should be asked how they define "success" of community consultation and public disclosure. Research on community attitudes is critical. Ways to continue/add to research include the following: research including major National Institutes of Health/Centers for Disease Control and Prevention funding acquisition for evaluation of the clinical impact of EFIC research; education for research funding agencies about emergency research, including current outcomes (e.g., survival rates); participation of emergency medicine researchers in meetings of research ethicists/IRB members (Public Responsibility in Medicine and Research/Applied Research Ethics National Association); publication of experiences and of the effects of EFIC research; future update meetings such as this one at the Society for Academic Emergency Medicine meeting; and more membership on IRBs of emergency physicians. While IRBs must approve EFIC research based on their own local environment, additional guidelines from regulatory agencies may be helpful. In general, current treatments for EFIC conditions are unsatisfactory and many are unproven. A group of peer reviewers can act as consultants to IRBs that do not have this expertise.
对于紧急研究中知情同意豁免(EFIC)要求的最终规则,不同的解读导致实施过程中出现不一致,一些机构审查委员会(IRB)在批准此类研究时也面临困难。在《学术急诊医学》编辑委员会组织的一次共识研讨会上,与会者讨论了IRB如何平衡EFIC研究中对人类受试者的风险、社区咨询的开展及其在IRB决策中的作用,以及改进和研究EFIC效果的未来方向。确定了共识领域和意见分歧。研讨会上,采用了美国国立卫生研究院的共识建立模式,以制定与使用EFIC进行紧急研究的效果、方向、实施和最终目标等具体问题相关的声明。该项目包括对与EFIC或最终规则研究相关的历史和问题的概述,以及该研究领域专家观点的介绍。就主要议题达成了最终共识,包括IRB的视角、有效的社区咨询(通常被认为是实施EFIC研究的主要困难)以及该主题未来方向和研究的目标。采用了涉及相关方的圆桌讨论和分组会议的形式。关于IRB如何平衡风险,经协商一致同意,法规规定EFIC研究必须涉及未经证实或不尽人意的治疗。委员会一致认为,目前的复苏率不尽人意,因此当前的治疗方法也不尽人意。许多目前作为标准治疗使用的方法从未被证明是有效的。IRB和公众需要接受教育,了解复苏研究的必要性。对于该规则适用的其他情况也是如此。由于全国各地IRB的专业知识存在差异,应设立一组同行评审员作为顾问,以帮助IRB确定某种疾病的当前治疗方法是否未经证实或不尽人意。关于社区咨询,他人的经验作为指导很重要且有帮助。社区咨询的数量和形式应与所提议研究涉及的风险程度相对应。关于未来方向,应询问社区如何定义社区咨询和公开披露的“成功”。对社区态度的研究至关重要。继续/增加研究的方法包括:开展研究,包括获得美国国立卫生研究院/疾病控制与预防中心的主要资金,以评估EFIC研究的临床影响;对研究资助机构进行关于紧急研究的教育,包括当前的结果(如生存率);急诊医学研究人员参与研究伦理学家/IRB成员的会议(医学与研究中的公共责任/应用研究伦理全国协会);发表EFIC研究的经验和效果;在学术急诊医学协会会议上举行类似本次的未来更新会议;以及增加急诊医生在IRB中的成员数量。虽然IRB必须根据其当地环境批准EFIC研究,但监管机构的额外指导方针可能会有所帮助。总体而言,目前针对EFIC情况的治疗方法不尽人意,许多方法未经证实。一组同行评审员可以作为没有此类专业知识IRB的顾问。